Cite
HARVARD Citation
Lord, R. et al. (2020). Real world outcomes in platinum sensitive relapsed ovarian, fallopian tube, or peritoneal cancer treated in routine clinical practice in the United Kingdom prior to poly-ADP ribose polymerase inhibitors. International journal of gynecological cancer. 30 (7), pp. 1026-1033. [Online].